Ion channels may be the Achilles’ heel of the SARS-CoV-2 virus, with research emerging from Israel that identified eight already-approved compounds that inhibit the activity of the E-protein channels in the virus’ membrane.
https://www.pharmalive.com/wp-content/uploads/2021/08/E-Protein-Channel-Blockers-May-Lead-the-Next-Fight-Against-COVID-19-BioSpace-8-20-21.jpeg350625Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2021-08-20 16:06:052021-08-20 16:38:28E-Protein Channel Blockers May Lead Next Fight Against COVID-19